Skip to main content
Premium Trial:

Request an Annual Quote

Chip-Man Moves to New HQ, Starts Shipping Cell Analysis Tools in Europe for Evaluation

NEW YORK, July 29 (GenomeWeb News) - Chip-Man Technologies of Tampere, Finland, has moved into new facilities, the company said today.

 

The purpose-built, 270 square meter (2,900 square feet) facility will help the firm to "optimize our operations and also place us at the heart of the exciting new biomedical hub being formed in Tamperefor regenerative medicine," according to a company statement.

 

Chip-Man is now starting to release its Cell-IQ cell imaging system to various sites in Europefor evaluation. Cell-IQ monitors morphological and physiological changes in cell lines, primary cells, co-cultures, and monolayer tissue models in real time.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.